Cargando…

Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Marcus Vinicius Santos, Andrade, Luciana Azevedo Prata, Bispo, Alan Freitas, Freitas, Luana de Alencar, Andrade, Milena Quadros Sampaio, Feitosa, Gilson Soares, Feitosa-Filho, Gilson Soares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://www.ncbi.nlm.nih.gov/pubmed/30088558
http://dx.doi.org/10.5935/abc.20180137
_version_ 1783361109085913088
author Andrade, Marcus Vinicius Santos
Andrade, Luciana Azevedo Prata
Bispo, Alan Freitas
Freitas, Luana de Alencar
Andrade, Milena Quadros Sampaio
Feitosa, Gilson Soares
Feitosa-Filho, Gilson Soares
author_facet Andrade, Marcus Vinicius Santos
Andrade, Luciana Azevedo Prata
Bispo, Alan Freitas
Freitas, Luana de Alencar
Andrade, Milena Quadros Sampaio
Feitosa, Gilson Soares
Feitosa-Filho, Gilson Soares
author_sort Andrade, Marcus Vinicius Santos
collection PubMed
description BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomized clinical trials, but no large study has examined in detail the risk of bleeding during dental extraction and other dental procedures involving bleeding. OBJECTIVE: To compare the intensity of bleeding in individuals taking dabigatran or vitamin K antagonist (warfarin) and undergoing dental procedures. METHODS: Prospective, single-center, controlled study with one single observer. Patients diagnosed with nonvalvular AF, on warfarin or dabigatran, cared for at a cardiology referral center, and requiring single or multiple dental extractions, were evaluated up to seven days post-extraction. The following outcomes were assessed: bleeding time between the beginning and the end of suture and complete hemostasis; bleeding before the procedure, after 24 hours, 48 hours, 7 days, during and after suture removal (late); p<0.05 was defined as of statistical relevance. RESULTS: We evaluated 37 individuals, 25 in the warfarin group and 12 in the dabigatran group. Age, sex, weight, height, blood pressure, color, schooling, family income and comorbidities were similar between the two groups. Regarding bleeding after 24 hours of the procedure, no one in the dabigatran group had bleeding, whereas 32% in the warfarin group had documented bleeding (p = 0.028). The other variables analyzed did not differ between the groups. CONCLUSIONS: This study suggests that, regarding dental extraction, there is no statistically significant difference in the intensity of bleeding of patients taking dabigatran as compared to those taking warfarin. Bleeding 24 hours after the procedure was less frequent among patients on dabigatran.
format Online
Article
Text
id pubmed-6173350
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Cardiologia - SBC
record_format MEDLINE/PubMed
spelling pubmed-61733502018-10-10 Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures Andrade, Marcus Vinicius Santos Andrade, Luciana Azevedo Prata Bispo, Alan Freitas Freitas, Luana de Alencar Andrade, Milena Quadros Sampaio Feitosa, Gilson Soares Feitosa-Filho, Gilson Soares Arq Bras Cardiol Original Article BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomized clinical trials, but no large study has examined in detail the risk of bleeding during dental extraction and other dental procedures involving bleeding. OBJECTIVE: To compare the intensity of bleeding in individuals taking dabigatran or vitamin K antagonist (warfarin) and undergoing dental procedures. METHODS: Prospective, single-center, controlled study with one single observer. Patients diagnosed with nonvalvular AF, on warfarin or dabigatran, cared for at a cardiology referral center, and requiring single or multiple dental extractions, were evaluated up to seven days post-extraction. The following outcomes were assessed: bleeding time between the beginning and the end of suture and complete hemostasis; bleeding before the procedure, after 24 hours, 48 hours, 7 days, during and after suture removal (late); p<0.05 was defined as of statistical relevance. RESULTS: We evaluated 37 individuals, 25 in the warfarin group and 12 in the dabigatran group. Age, sex, weight, height, blood pressure, color, schooling, family income and comorbidities were similar between the two groups. Regarding bleeding after 24 hours of the procedure, no one in the dabigatran group had bleeding, whereas 32% in the warfarin group had documented bleeding (p = 0.028). The other variables analyzed did not differ between the groups. CONCLUSIONS: This study suggests that, regarding dental extraction, there is no statistically significant difference in the intensity of bleeding of patients taking dabigatran as compared to those taking warfarin. Bleeding 24 hours after the procedure was less frequent among patients on dabigatran. Sociedade Brasileira de Cardiologia - SBC 2018-09 /pmc/articles/PMC6173350/ /pubmed/30088558 http://dx.doi.org/10.5935/abc.20180137 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Andrade, Marcus Vinicius Santos
Andrade, Luciana Azevedo Prata
Bispo, Alan Freitas
Freitas, Luana de Alencar
Andrade, Milena Quadros Sampaio
Feitosa, Gilson Soares
Feitosa-Filho, Gilson Soares
Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
title Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
title_full Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
title_fullStr Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
title_full_unstemmed Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
title_short Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
title_sort evaluation of the bleeding intensity of patients anticoagulated with warfarin or dabigatran undergoing dental procedures
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://www.ncbi.nlm.nih.gov/pubmed/30088558
http://dx.doi.org/10.5935/abc.20180137
work_keys_str_mv AT andrademarcusviniciussantos evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures
AT andradelucianaazevedoprata evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures
AT bispoalanfreitas evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures
AT freitasluanadealencar evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures
AT andrademilenaquadrossampaio evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures
AT feitosagilsonsoares evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures
AT feitosafilhogilsonsoares evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures